William Matsui
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation 27
- Multiple Myeloma Research and Treatments 25
- Acute Myeloid Leukemia Research 13
- Oncology top 0.2%
- Cancer Cells and Metastasis 35
- Pancreatic and Hepatic Oncology Research 16
- Cancer Research top 1%
- Genetics top 0.5%
- Molecular Biology top 0.5%
- Hedgehog Signaling Pathway Studies 28
- Epigenetics and DNA Methylation 25
-
- Immune Cell Function and Interaction 12
- Co-authors
- Richard J. JonesCarol Ann HuffAkil MerchantCharles G. EberhartZeshaan A. RasheedAnirban MaitraQiuju WangJames Barber
- Cited by
- HematologyOncologyCancer Research
- Journals
- Blood (28 papers)Biology of Blood and Marrow Transplantation (13 papers)Cancer Research (9 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
William Matsui
153 papers receiving 10.6k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Hematology 2.5k
- Oncology 5.3k
- Cancer Research 1.7k
- Genetics 1.1k
- Molecular Biology 6.1k
Countries citing papers authored by William Matsui
This map shows the geographic impact of William Matsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Matsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Matsui more than expected).
Fields of papers citing papers by William Matsui
This network shows the impact of papers produced by William Matsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Matsui. The network helps show where William Matsui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside William Matsui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 21 | |
| 3 | 2023 | 25 | |
| 4 | 2019 | 12 | |
| 5 | 2016 | 7 | |
| 6 | 2016 | 234 | |
| 7 | 2014 | 22 | |
| 8 | 2013 | 125 | |
| 9 | 2012 | 72 | |
| 10 | 2010 | 278 | |
| 11 | 2009 | 149 | |
| 12 | 2009 | 150 | |
| 13 | 2009 | 11 | |
| 14 | Correlation of clonogenic cancer stem cell (CSC) growth with clinical outcomes in multiple myeloma (MM) patients undergoing treatment with high dose cyclophosphamide (Cy) and rituximab | 2008 | 5 |
| 15 | 2008 | 10 | |
| 16 | Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancersbreakdown → | 2007 | 537 |
| 17 | The novel telomerase inhibitor GRN163L targets drug-resistant cancer stem cells in multiple myeloma | 2007 | 1 |
| 18 | 2007 | 15 | |
| 19 | 2006 | 480 | |
| 20 | Expanding the toolbox of myeloma biology | 2005 | 1 |
About William Matsui
William Matsui is a scholar working on Hematology, Oncology and Genetics, having authored 154 papers that have together received 10.8k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (35 papers), Hedgehog Signaling Pathway Studies (28 papers), Hematopoietic Stem Cell Transplantation (27 papers), Multiple Myeloma Research and Treatments (25 papers), Epigenetics and DNA Methylation (25 papers), Pancreatic and Hepatic Oncology Research (16 papers), Acute Myeloid Leukemia Research (13 papers) and Immune Cell Function and Interaction (12 papers). The work is most often cited by research in Hematology (2.5k citations), Oncology (5.3k citations) and Cancer Research (1.7k citations). William Matsui has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Richard J. Jones, Carol Ann Huff, Akil Merchant, Charles G. Eberhart, Zeshaan A. Rasheed, Anirban Maitra, Qiuju Wang, James Barber, Xing Fan and B. Douglas Smith. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Cancer Research, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.